Stocks · Korea
317450
KOSPI
Myungin Pharm
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-07 basis
PER6.45x
PBR0.80x
EPS6,718 KRW
BPS54,409 KRW
ROE10.25%
Dividend yield3.46%
DPS1,500 KRW
Payout ratio22.33%
Returns and 52-week range
1W+2.60%
1M-2.91%
3M+1.52%
6M-20.31%
YTD-29.63%
52W high134,500원
52W low39,100원
From 52W high-67.77%
Financial results (consolidated)
| Period | Revenue | Operating income | Net income | OP margin |
|---|---|---|---|---|
| 2025 | 2,873억 | 925억 | 814억 | 32.2% |
| Quarterly | ||||
| 2025 3Q | 727억 | 219억 | 185억 | 30.1% |
| 2026 1Q | 721억 | 251억 | 227억 | 34.8% |
Company
Address: 경기도 화성시 팔탄면 노하길 361-12
Peers in the same sector
Recent filings
- 2026-08-13반기보고서 (2026.06)
- 2026-05-14분기보고서 (2026.03)
- 2026-03-25[기재정정]사업보고서 (2025.12)
- 2026-03-18사업보고서 (2025.12)
- 2025-11-12분기보고서 (2025.09)
Source: DART (Financial Supervisory Service electronic disclosure)
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.